Overexpression of the phosphatase of regenerating liver (PRL) phosphatases—PRL1, PRL2, and/or PRL3, occurs in many human cancers and often correlate with metastasis or poor disease prognosis (1–4). This evidence concerns the gene PTP4A2 and cancer.